Hormone therapy as a management strategy for lung metastasis after 5 years of endometrial cancer: A case report and literature review

    loading  Checking for direct PDF access through Ovid



Endometrial cancer patients with lung metastases are rare, and more rarely with long-term management of progesterone after recurrence.

Patient concerns:

Informed consent of the patients and their families.


Endometrial cancer (IVB) (Refer to 2009 FIGO stag of endometrial cancer).


the patient was treated with Megestrol Acetate Dispersible Tablets (trade name Yilizhi), 160 mg, orally, once daily, without interruption.


The patient has been treated with progesterone therapy for stable conditions and her survival time is already roughly a decade (December 2006–October 2016).


Hormone therapy may as a long-term management for hormone receptor-positive patients with recurrent endometrial cancer.

Related Topics

    loading  Loading Related Articles